Loading clinical trials...
Loading clinical trials...
A Comparison of Haloperidol 5mg IM vs Droperidol 2.5mg and Ondansetron for the Treatment of Hyperemesis in Cannabis Hyperemesis Syndrome
Conditions
Interventions
Droperidol
Haloperidol
+1 more
Locations
1
United States
Lakeland Regional Healthcare
Saint Joseph, Michigan, United States
Start Date
August 30, 2021
Primary Completion Date
November 20, 2023
Completion Date
November 20, 2023
Last Updated
May 21, 2025
Lead Sponsor
Corewell Health South
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions